PGGM Investments trimmed its holdings in Johnson & Johnson (NYSE:JNJ) by 18.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,738,947 shares of the company’s stock after selling 621,635 shares during the period. Johnson & Johnson accounts for about 1.9% of PGGM Investments’ holdings, making the stock its 4th biggest holding. PGGM Investments owned 0.10% of Johnson & Johnson worth $362,335,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of JNJ. Cable Hill Partners LLC raised its position in shares of Johnson & Johnson by 2.1% in the first quarter. Cable Hill Partners LLC now owns 4,113 shares of the company’s stock valued at $512,000 after buying an additional 85 shares during the last quarter. Grubman Wealth Management acquired a new stake in shares of Johnson & Johnson in the first quarter valued at about $286,000. Lenox Wealth Advisors Inc. raised its position in shares of Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock valued at $108,000 after buying an additional 6 shares during the last quarter. Burke & Herbert Bank & Trust Co. raised its position in shares of Johnson & Johnson by 2.6% in the first quarter. Burke & Herbert Bank & Trust Co. now owns 47,330 shares of the company’s stock valued at $5,895,000 after buying an additional 1,218 shares during the last quarter. Finally, Berson & Corrado Investment Advisors LLC raised its position in shares of Johnson & Johnson by 0.7% in the first quarter. Berson & Corrado Investment Advisors LLC now owns 2,835 shares of the company’s stock valued at $353,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 65.90% of the company’s stock.

In other Johnson & Johnson news, VP Paulus Stoffels sold 102,692 shares of Johnson & Johnson stock in a transaction dated Monday, July 24th. The stock was sold at an average price of $133.14, for a total value of $13,672,412.88. Following the completion of the sale, the vice president now owns 230,342 shares in the company, valued at approximately $30,667,733.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Dominic J. Caruso sold 82,591 shares of Johnson & Johnson stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $136.72, for a total value of $11,291,841.52. Following the completion of the sale, the vice president now owns 226,693 shares of the company’s stock, valued at approximately $30,993,466.96. The disclosure for this sale can be found here. 0.19% of the stock is owned by insiders.

JNJ has been the subject of a number of recent research reports. BidaskClub upgraded shares of Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Royal Bank Of Canada reissued a “buy” rating and issued a $128.00 price objective on shares of Johnson & Johnson in a report on Thursday, June 15th. Atlantic Securities lowered shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 price objective for the company. in a report on Friday, July 21st. Jefferies Group LLC reissued a “hold” rating and issued a $145.00 price objective (up previously from $140.00) on shares of Johnson & Johnson in a report on Friday, July 14th. Finally, Citigroup Inc. assumed coverage on shares of Johnson & Johnson in a report on Monday, September 25th. They issued a “neutral” rating and a $140.00 price objective for the company. Six investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $135.52.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/johnson-johnson-jnj-shares-sold-by-pggm-investments/1601551.html.

Shares of Johnson & Johnson (NYSE:JNJ) traded up 0.42% on Friday, reaching $130.01. 5,736,925 shares of the company’s stock traded hands. The stock has a market capitalization of $348.95 billion, a price-to-earnings ratio of 22.00 and a beta of 0.79. Johnson & Johnson has a 52 week low of $109.32 and a 52 week high of $137.08. The stock’s 50-day moving average price is $132.79 and its 200-day moving average price is $129.43.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.79 by $0.04. The company had revenue of $18.84 billion during the quarter, compared to analysts’ expectations of $18.94 billion. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The firm’s revenue was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.74 EPS. Equities analysts predict that Johnson & Johnson will post $7.18 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were issued a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.58%. The ex-dividend date was Friday, August 25th. Johnson & Johnson’s dividend payout ratio (DPR) is 56.76%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.